Theodore Tulloch

Amoebics has developed a novel approach to tackle bacterial infections. Using a new technology, developed at Edinburgh University, Ameobics is producing antibacterial drugs that promise to be effective in the treatment of infections arising from bacteria, including bacteria that are resistant to treatment by antibiotics. The company was established in 1998 to commercialize work carried out in the laboratory of Dr. Sutherland Maciver in the Medical School of Edinburgh University. With a mix of equity and grant funding, the company has progressed its first product to the point of early preclinical testing. Results to date are very encouraging in terms of support for the firm's first product and also demonstrate the overall potential of the new technology to tackle a range of bacterial infections.

Scottish American Investment Co. Plc is a closed-end investment trust. It focuses on the portfolio of listed equities, both UK and overseas, but investments are also made in bonds, property and other asset types. Its investment objective is to grow the dividend at a faster rate than inflation by increasing capital and growing income. The fund’s investment management services are provided by Baillie Gifford & Co. The company was founded by William Menzies on March 29, 1873 and is headquartered in Edinburgh, the United Kingdom.

Global Opportunities Trust Plc is a closed-end investment fund and investment trust. Its investment objective is to provide shareholders with real long-term total return by investing globally in undervalued securities. The company was founded on November 13, 2003, and is headquartered in Edinburgh, the United Kingdom.

Part of Commonwealth Bank of Australia, Stewart Ivory & Co. Ltd. is a British company that manages investment trusts and other investment portfolios. The company is based in Edinburgh, UK. Stewart Ivory & Co. was acquired by Colonial Pty Ltd., a SUB of Commonwealth Bank of Australia from Scottish American Investment Co. Plc on March 24, 2000 for $115.29 million.